120 related articles for article (PubMed ID: 8755836)
1. [Comparison of the ability to control anemia in patients on hemodialysis and peritoneal dialysis considering iron reserves and plasma erythropoietin].
Majdan M; Ksiazek A; Spasiewicz D
Pol Arch Med Wewn; 1996 Apr; 95(4):307-12. PubMed ID: 8755836
[TBL] [Abstract][Full Text] [Related]
2. Changes of endogenous erythropoietin level and iron status during a 30-month hemodialysis treatment of a group of patients.
Majdan M; Ksiazek A; Bednarek-Skublewska A; Spasiewicz D
Int Urol Nephrol; 2001; 33(3):541-6. PubMed ID: 12230292
[TBL] [Abstract][Full Text] [Related]
3. Improved response to erythropoietin in peritoneal dialysis patients as compared to hemodialysis patients: role of iron deficiency.
Raja R; Bloom E; Johnson R; Goldstein M
Adv Perit Dial; 1994; 10():135-8. PubMed ID: 7999811
[TBL] [Abstract][Full Text] [Related]
4. Recombinant human erythropoietin dosage in children undergoing hemodialysis and continuous ambulatory peritoneal dialysis.
Sieniawska M; Roszkowska-Blaim M
Pediatr Nephrol; 1997 Oct; 11(5):628-30. PubMed ID: 9323294
[TBL] [Abstract][Full Text] [Related]
5. Comparison of plasma erythropoietin concentrations and iron status in hemodialyzed patients not requiring and requiring rHuEpo therapy.
Majdan M; Ksiazek A; Kozioł M; Spasiewicz D; Swatowski A; Solski J
Nephron; 1996; 73(3):425-9. PubMed ID: 8832602
[TBL] [Abstract][Full Text] [Related]
6. Does parathyroid hormone affect erythropoietin therapy in dialysis patients?
Al-Hilali N; Al-Humoud H; Ninan VT; Nampoory MR; Puliyclil MA; Johny KV
Med Princ Pract; 2007; 16(1):63-7. PubMed ID: 17159367
[TBL] [Abstract][Full Text] [Related]
7. Comparison of magnesium and zinc levels in blood in end stage renal disease patients treated by hemodialysis or peritoneal dialysis.
Pietrzak I; Bladek K; Bulikowski W
Magnes Res; 2002 Dec; 15(3-4):229-36. PubMed ID: 12635877
[TBL] [Abstract][Full Text] [Related]
8. [Clinical analysis of CAPD-treated patients without anemia].
Majdan M; Grzebalska AM; Mierzicki P; Berger-Smyka B; Bober E; Orłowska A; Ksiazek A
Wiad Lek; 2003; 56(1-2):14-8. PubMed ID: 12901262
[TBL] [Abstract][Full Text] [Related]
9. Plasma erythropoietin level and iron reserves in haemodialysis patients with and without acquired cystic kidney disease.
Majdan M; Ksiazek A; Kozioł M; Spasiewicz D
Int Urol Nephrol; 1997; 29(1):113-8. PubMed ID: 9203047
[TBL] [Abstract][Full Text] [Related]
10. Subcutaneous recombinant human erythropoietin in hemodialysis and continuous ambulatory peritoneal dialysis.
Pais MJ; Gaspar A; Santana A; Bruges M; Simões J
Perit Dial Int; 1993; 13 Suppl 2():S541-3. PubMed ID: 8399660
[TBL] [Abstract][Full Text] [Related]
11. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietin requirements: a comparative multicenter study between peritoneal dialysis and hemodialysis.
Coronel F; Herrero JA; Montenegro J; Fernandez C; Gandara A; Conesa J; Rivera MT; Torrente J; Portolés J; Gomez-Martino JR
J Nephrol; 2003; 16(5):697-702. PubMed ID: 14733416
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin associated hypertension among pediatric dialysis patients.
Komatsu Y; Ito K
Adv Perit Dial; 1992; 8():448-52. PubMed ID: 1361845
[TBL] [Abstract][Full Text] [Related]
14. Comparative effects of erythropoietin with oral iron in peritoneal dialysis and hemodialysis patients.
Raja R; Bloom E; Johnson R
Adv Perit Dial; 1993; 9():177-80. PubMed ID: 8105918
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of the iron metabolism and effectiveness of anemia treatment in patients on maintenance hemodialysis performed based on polysulfone and helixone dialyzers].
Sobaszek-Pitas M; Krzanowska K; Sułowicz W
Przegl Lek; 2014; 71(8):418-22. PubMed ID: 25546912
[TBL] [Abstract][Full Text] [Related]
16. The red blood cell deformability in patients suffering from end stage renal failure on hemodialysis or continuous ambulatory peritoneal dialysis.
Sotirakopoulos N; Tsitsios T; Stambolidou M; Athanasiou G; Peiou M; Kokkinou V; Mavromatidis K
Ren Fail; 2004 Mar; 26(2):179-83. PubMed ID: 15287203
[TBL] [Abstract][Full Text] [Related]
17. Chapter 8 Haemoglobin, ferritin and erythropoietin amongst UK adult dialysis patients in 2010: national and centre-specific analyses.
Webb L; Gilg J; Wilkie M
Nephron Clin Pract; 2012; 120 Suppl 1():c145-74. PubMed ID: 22964566
[TBL] [Abstract][Full Text] [Related]
18. Plasma myeloperoxidase, NT-proBNP, and troponin-I in patients on CAPD compared with those on regular hemodialysis.
Al-Hweish A; Sultan SS; Mogazi K; Elsammak MY
Hemodial Int; 2010 Jul; 14(3):308-15. PubMed ID: 20597992
[TBL] [Abstract][Full Text] [Related]
19. [Anemia in patients on continuous ambulatory peritoneal dialysis (CAPD)].
Tokuda Y; Itou H; Uchida Y; Azuma K; Ohtsuka H; Uomizu K; Yamashita W; Harada R; Nakashima A; Morita T
Fukuoka Igaku Zasshi; 1989 Jul; 80(7):379-84. PubMed ID: 2807127
[TBL] [Abstract][Full Text] [Related]
20. Leptin and serum erythropoietin in hemodialyzed and peritoneally dialyzed uremic patients during rHuEPO therapy.
Małyszko J; Zbroch E; Wołczyński S; Małyszko JS; Hryszko T; Myśliwiec M
Am J Nephrol; 2000; 20(3):180-6. PubMed ID: 10878398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
